Members of our Early Career Panel highlight key research articles on the theme of drug repurposing-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Members of our Early Career Panel highlight key research articles on the theme of drug repurposing

Published:2020-04-01 Issue:2 Volume:2 Page:
ISSN:2631-3316
Container-title:Future Drug Discovery
language:en
Short-container-title:Future Drug Discovery

Author:

Miljković Filip¹,Xiong Rui²,Sivakumar Dakshinamurthy³,Brown Christopher Alan⁴

Affiliation:

1. Data Science & Artificial Intelligence, Imaging & Data Analytics, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden

2. UIC College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60612, USA

3. Max Planck Institute for Dynamics of Complex Technical Systems, Sandtorstraße, 39106, Magdeburg, Germany

4. Charles River Laboratories, 8-9 The Spire Green Centre, Harlow, CM19 5TR, UK

Publisher

Future Science Ltd

Link

https://www.future-science.com/doi/pdf/10.4155/fdd-2020-0009

Reference6 articles.

1. Discovering the anticancer potential of non-oncology drugs by systematic viability profiling

2. The PRISM drug repurposing resource. Broad Institute, MA, USA (2020). https://depmap.org/repurposing/

3. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

4. In Vitro Activation of Cytochrome P450 46A1 (CYP46A1) by Efavirenz-Related Compounds

5. Olaparib significantly delays photoreceptor loss in a model for hereditary retinal degeneration

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Welcome to Volume 3 of Future Drug Discovery;Future Drug Discovery;2021-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP